As global markets navigate geopolitical tensions and economic uncertainties, Asian equities have shown resilience, with some indices maintaining stability amid fluctuating conditions. In this environment, identifying undervalued stocks can offer opportunities for investors seeking to capitalize on potential market inefficiencies. Recognizing a good stock often involves assessing its intrinsic valu...
As global markets navigate geopolitical tensions and economic uncertainties, Asian equities have shown resilience, with some indices maintaining stability amid fluctuating conditions. In this environment, identifying undervalued stocks can offer opportunities for investors seeking to capitalize on potential market inefficiencies. Recognizing a good stock often involves assessing its intrinsic value relative to its current price, especially in regions like Asia where emerging economic trends...
Nemes Laszlo Johnson & Johnson ( JNJ ) said it is discontinuing development for its CD20 mono CAR-T cell therapy and CD19-CD20 bi-CAR-T programs, all for treatment of B-cell lymphoma. "This is a strategic business decision based on the Company’s portfolio priorities and an assessment of the evolving large B-cell lymphoma treatment landscape," the company said in a statement . J&J added that enroll...
Nemes Laszlo Johnson & Johnson ( JNJ ) said it is discontinuing development for its CD20 mono CAR-T cell therapy and CD19-CD20 bi-CAR-T programs, all for treatment of B-cell lymphoma. "This is a strategic business decision based on the Company’s portfolio priorities and an assessment of the evolving large B-cell lymphoma treatment landscape," the company said in a statement . J&J added that enrolled patients in trials "will continue to be supported." More on Johnson & Johnson Johnson & Johnson: Why I See Downside Ahead Johnson & Johnson (JNJ) Q1 2026 Earnings Call Transcript Johnson & Johnson Q1 Earnings Review: Why You Should Be Buying The Stock Today J&J's Xarelto, Invokana to become available through TrumpRx J&J to buy private MedTech Atraverse to boost cardiac ablation portfolio
Jibril Rajoub refuses handshake at Fifa congress Infantino to seek third term as president The Fifa president, Gianni Infantino, confirmed his intention to stand for re-election for a third full term next year after an attempt to orchestrate a handshake between the Palestinian and Israeli delegates at congress backfired. The Palestinian Football Federation president, Jibril Rajoub, refused to stan...
Jibril Rajoub refuses handshake at Fifa congress Infantino to seek third term as president The Fifa president, Gianni Infantino, confirmed his intention to stand for re-election for a third full term next year after an attempt to orchestrate a handshake between the Palestinian and Israeli delegates at congress backfired. The Palestinian Football Federation president, Jibril Rajoub, refused to stand alongside Israel FA vice-president, Basim Sheikh Suliman, in an awkward moment towards the end of the 76th Fifa congress after both men had been called to the stage in Vancouver by Infantino. Continue reading...